N/A N=23 Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain
Cervical Radiculopathy
Primary: Upper Limb Neurodynamic Tesnion (UNLT) Range of Motion — 4.60; 16.00 degrees
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=5 Optical Measurements of the Skin Surface to Infer Distinctions in Myofascial Tissue Stiffness
Tissue Pain
Primary: Skin Stretch Response to Manual Lateral Pull — 0.512; 0.494; 0.508; 0.473 %/mm
N/A N=91 Flexion Versus Extension Soft Tissue Repair in Total Knee Arthroplasty
Total Knee Arthroplasty(TKA) · Total Knee Replacement
Primary: Knee Range of Motion (ROM) — 119; 120 degree
N/A N=24 To Compare Different Soft Tissue Grafts at the Time of Lateral Ridge Augmentation Procedure.
Bone Graft; Complications, Infection or Inflammation · Ridge Deficency · Dental Implant
Primary: Measure Changes Clinically in Crestal Soft Tissue Thickness (in mm) — 1.96; 1.59; 0.33 mm
N/A N=10 Transmitted Light Tissue Thickness Analysis (TiLTT)
Morbid Obesity
Primary: Number of Patients With Transmitted Light Intensity to Gastric Wall Thickness) — 10 Participants
N/A N=6 Customized Impressions in Dental Implants - Soft Tissues Changes
Soft Tissue
Primary: Changes in Soft Tissues Around Implant — 243.89 root mean square in µm
N/A N=9 (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas
Stage IV Adult Soft Tissue Sarcoma · Sarcoma,Soft Tissue
Primary: Number of Adverse Events of Grade ≥ 3 by CTCAE Criteria. — 8 events
N/A N=35 Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall
Soft Tissue Sarcoma
Primary: Local Disease Control Assessed by Physical Examination — 0 Participants
Phase 2 N=141 The Fibrin Patch Soft Tissue Study
Hemostasis
Primary: Proportion of Subjects Achieving Hemostatic Success — 98.3; 53.3; 98.0 percentage of success
Phase 2 N=58 A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
Recurrent Adult Soft Tissue Sarcoma · Stage III Adult Soft Tissue Sarcoma · Stage IV Adult Soft Tissue Sarcoma
Primary: Percentage of Patients With Progression-free Survival at 16 Weeks. — 36.4 Percentage of patients
N/A N=420 Emergency Bedside Ultrasound for Pediatric Soft Tissue Infections
Abscess
Primary: Sensitivity and Specificity of Bedside Emergency Ultrasound When Added to the Clinical Examination Compared With Clinical Examination Alone. — 94.7; 93.1; 84.2; 81.4…
N/A N=42 Quantifying Myofascial Dysfunction in Post-Stroke Pain
Myofascial Dysfunction
Primary: T1 Rho MRI Relaxation Time of Shoulder External Rotator (Milliseconds) — 29.09; 27.15 milliseconds
N/A N=45 Scleroderma ARFI Imaging of the Skin
Scleroderma
Primary: Mean Skin Stiffness — 2.68; 2.07; 2.23; 2.27 meters per second — p=0.005
N/A N=10 RF/PEMF Versus Ultrasound for the Treatment of Soft Tissue Injury
Soft Tissue Injuries
Primary: Mean Reduction in BPI-SF Severity — 2.75; 2.44 score on a scale
N/A N=27 Implant Placement With Simultaneous Gum Grafting
Edentulous
Primary: Soft Tissue Thickness Over the Implant — 0.6; 0.4 mm
N/A N=24 A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction
Tooth Extraction
Primary: Change in Buccal Plate Thickness From Baseline to Month 6 — 1.85; 1.25 mm — p=0.11
Phase 3 N=588 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Adult Alveolar Soft-part Sarcoma · Adult Angiosarcoma · Adult Epithelioid Sarcoma
Primary: Probability for Event Free Survival. — 0.8984; 0.7647; 0.6079; 0.4873 Probability of EFS at 5 years
N/A N=30 Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation
Gingival Diseases
Primary: Keratinized Tissue Width — 4.42; 2.92 mm — p=<0.0001
Phase 4 N=46 Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation
Dental Implant · Immediate Dental Implant · Soft Tissue Augmentation
Primary: Change in Ridge Dimension — -1.65; -1.87; -1.44; -1.37 millimeters (mm)
N/A N=274 A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas.
Sarcoma
Primary: Adherence Rate to Diagnosis Imaging Guidelines for Patients With a Deep Sarcoma Tumor (Before Implementation of the Public Health Intervention Programme. — 145…
N/A N=19 Tissue Optimization on Cryolipolysis Procedures for Fat Layer Reduction
Body Fat Disorder
Primary: Percentage of Before and After Side-by-side Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer (IPR) Panel…
N/A N=7 A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall
Soft Tissue Sarcoma
Primary: Late Radiation Toxicities at 2 Years From the Start of Radiation Treatment — 0 Participants
Phase 2 N=267 A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma
Malignant Rhabdoid Tumors (MRT) · Rhabdoid Tumors of the Kidney (RTK) · Atypical Teratoid Rhabdoid Tumors (ATRT)
Primary: Cohorts 1, 3, 4, 5, 6 and 7: Objective Response Rate (ORR) — 9.4; 9.4; 0.0; 16.1 Percentage of participants
N/A N=25 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Peripheral Artery Disease · PAD · Claudication
Primary: Rate of Clinically Driven Target Lesion Revascularization (TLR) — 4.0; 8.2 % probablity of clinically driven TLR
Phase 2 N=20 Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
Soft Tissue Sarcoma
Primary: Number of Participants With Enhanced T Lymphocyte Immune Response Specific for Soft Tissue Sarcoma Tumor Associated Antigens(STS-TAAs) — 2; 5 participants
N/A N=2 Feasibility Study: Heavy Water Tissue Labeling Protocol
Skin Laxity
Primary: Rate of Collagen Synthesis — 15.71; 21.22; 36.11; 51.80 percentage of new collagen synthesized
N/A N=14 To Compare Free Gingival Grafts and Connective Tissue Grafts Around Implants With Lack of Keratinized Mucosa
Dental Implants · Alveolar Mucosa
Primary: The Increase in Keratinized Mucosa (in mm) Between the Two Grafts — 3.29; 1.29 mm
N/A N=34 SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery
Subjects Requiring Revision Breast Augmentation Surgery
Primary: Reoperation Rate (Per Implanted Breast) for the Presenting Condition at 12 Months. — 0; 0 Implanted breasts
N/A N=17 Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)
Traumatic Injury · Muscle Injury · Tendon Injury
Primary: Percent Change From Baseline in the Rectified and Integrated EMG Signal of the Tibialis Anterior Muscle At 24 Weeks Post-Operative — 1333 % change
Phase 2 N=98 Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
Lymphedema · Musculoskeletal Complications · Radiation Fibrosis
Primary: Rate of Late Radiation Morbidity (≥ Grade 2 Lymphedema, Subcutaneous Fibrosis, or Joint Stiffness) at 2 Years From the Start of Radiotherapy as Measured by EORTC/RTOG…